The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of revumenib in patients (pts) with advanced colorectal cancer (CRC) and other solid tumors.
 
Aparna Parikh
Stock and Other Ownership Interests - CADEX Genomics; OneCell Diagnostics India; Parithera; X genomes
Consulting or Advisory Role - 3T BioSciences; Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; CareSet; Caris Life Sciences; Checkmate Pharmaceuticals; CVS; Delcath Systems; DoMore Diagnostics; Exact Sciences; Foundation Medicine; GlaxoSmithKline; Guardant Health; Illumina; Incyte; Lilly; Merck; MPM Capital; Natera; Pfizer; Phesi; Regeneron; SAGA Diagnostics; Seagen; Summit pharmaceuticals; Taiho Oncology; Takeda; Takeda; Third Rock Ventures; UpToDate; Value Analytics Labs; Value Analytics Labs; Xilio Therapeutics; Zola
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); PMV Pharma; PureTech (Inst); Syndax
Travel, Accommodations, Expenses - Karkinos Healthcare; Karkinos Healthcare
Other Relationship - C2i genomics; CADEX Genomics; Parithera; Xact Robotics
 
Kristen Ciombor
Consulting or Advisory Role - Agenus; ALX Oncology; Bayer; BeiGene; Exact Sciences; Exelixis; Incyte; Merck; Pfizer; Summit Therapeutics; Taiho Oncology; Tempus
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Pfizer/Calithera (Inst); Sanofi (Inst); Seagen (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Incyte; Tempus
 
Nashat Gabrail
Consulting or Advisory Role - Celgene; Chemiocare
Speakers' Bureau - Janssen Oncology; Janssen Oncology; Janssen Oncology; Karyopharm Therapeutics; Taiho Pharmaceutical; Taiho Pharmaceutical; Tesaro/GSK
Research Funding - Amgen (Inst); Bayer (Inst); Chemiocare (Inst); Chemiocare (Inst); Kartos Therapeutics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Oncology Supply
 
Jessica Clement
Employment - Surface Oncology; Syndax
Stock and Other Ownership Interests - Coherus Biosciences; Syndax
 
Braydon Schaible
Employment - Syndax
Stock and Other Ownership Interests - Syndax
 
Mila Ayash-Rashkovsky
Employment - Syndax
Stock and Other Ownership Interests - Syndax; Takeda
 
Maliha Nusrat
Travel, Accommodations, Expenses - Takeda
(OPTIONAL) Uncompensated Relationships - Haymarket Media
 
Sunil Sharma
Employment - VA Medical Center (I)
Leadership - Translational Genomics Institute
Stock and Other Ownership Interests - Black Canyon Bio; Bonneville; Stingray Therapeutics
Consulting or Advisory Role - Novelty Nobi; Processa Pharmaceuticals; Tisch Cancer Institute
 
Raymond Wadlow
Honoraria - Astellas Pharma; Oncocyte; Pfizer; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Johnson & Johnson (I)